Search for: "M.D. Janet Woodcock"
Results 21 - 40
of 47
Sorted by Relevance
|
Sort by Date
14 Apr 2009, 8:41 am
"The FDA wants patients and health care professionals to know about this risk so they can make informed decisions about treatment," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. [read post]
25 Nov 2009, 5:53 am
Janet Woodcock, said Congress would have to authorize a change in the existing monitoring system to make for these automatic updates. [read post]
25 Nov 2009, 5:53 am
Janet Woodcock, said Congress would have to authorize a change in the existing monitoring system to make for these automatic updates. [read post]
5 Dec 2011, 10:00 am
"This medication is widely used by people who must manage their high cholesterol over time, so it is important to have affordable treatment options," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. [read post]
3 Mar 2009, 3:36 pm
Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research said, “The chronic use of metoclopramide therapy should be avoided in all but rare cases where the benefit is believed to outweigh the risk. [read post]
30 Mar 2016, 1:42 pm
“The broad set of actions announced today is reflective of the FDA’s efforts to improve informed prescribing of opioids across the board,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. [read post]
17 Sep 2011, 5:43 am
Food and Drug Administration, The New England Journal of Medicine by Janet Woodcock, M.D., Joshua M. [read post]
31 Oct 2012, 2:26 pm
“Because the preliminary results of the FDA’s inspection raise concerns about the sterility assurance of Ameridose’s products, the FDA is advising health care professionals to stop using all Ameridose products and follow the recall procedures provided by the firm,” explained Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research.The FDA has identified some Ameridose products that currently appear on the critical… [read post]
28 May 2021, 9:05 pm
The budget request also seeks increases to help address complex challenges facing the country such as the ongoing opioid crisis and promoting health equity among underserved communities,” said Acting FDA Commissioner Janet Woodcock, M.D. [read post]
21 Feb 2021, 9:05 pm
Acting USDA Secretary Kevin Shea and Acting FDA Commissioner Janet Woodcock, M.D., issued a statement that takes exception to China’s latest contention about the origins of the coronavirus pandemic. [read post]
14 Oct 2019, 10:59 am
Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research states, “We have carefully assessed the valsartan-containing medications sold in the United States, and we’ve found that the valsartan sold by these specific companies does not meet our safety standards. [read post]
26 Jan 2023, 2:06 pm
This working group, led by FDA Principal Deputy Commissioner Janet Woodcock, M.D., has closely examined the existing scientific data related to CBD, including studies related to the CBD-based drug Epidiolex, published scientific literature, information submitted to a public docket, and studies both conducted and commissioned by the agency. [read post]
4 May 2020, 6:34 am
“Since we don’t know how or for how long the product might have been stored, we decided that it should not be available to consumers and patients unless its quality can be assured,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. [read post]
21 Feb 2023, 6:25 pm
FDA Principal Deputy Commissioner Janet Woodcock, M.D. issued the release on January 26th stating that she had chaired an FDA “high-level internal working group to explore potential regulatory pathways for CBD products. [read post]
16 Dec 2013, 11:00 am
“Antibacterial soaps and body washes are used widely and frequently by consumers in everyday home, work, school, and public settings, where the risk of infection is relatively low,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER). [read post]
9 May 2009, 2:14 am
“These drugs are approved for an important medical need, but can have serious, unintended side effects if not used properly,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. [read post]
8 Dec 2008, 2:29 pm
Rost, as an M.D., is qualified for the title. [read post]
17 Dec 2010, 11:00 am
"After careful review of the clinical data, we are recommending that the breast cancer indication for Avastin be removed based on evidence from four independent studies," Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. [read post]
3 May 2021, 4:45 am
With these actions, the FDA will help significantly reduce youth initiation, increase the chances of smoking cessation among current smokers, and address health disparities experienced by communities of color, low-income populations, and LGBTQ+ individuals, all of whom are far more likely to use these tobacco products,” said Acting FDA Commissioner Janet Woodcock, M.D. [read post]
30 Jul 2009, 11:32 am
"The FDA wants patients and health care professionals to know about this risk so they can make informed decisions about treatment," Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research, said in the agency's news release. [read post]
